Neogen Corporation

NG2.F·Frankfurt·Healthcare
Compare
10.86+0.25 (+2.41%)today
As of Nov 5, 8:04 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.60
Open10.86
Day range—
52-week range4.6812.07
Off day high0.00%
Off 52-week high−10.03%
Volume100
Avg. volume (3M)47.00
Market cap2.37B
EPS (TTM)-0.2200
Forward P/E14.47
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.86
Shares outstanding218.31M
Short interest—
Earnings dateOct 6, 2026 (est.)
Analyst target—
Profit margin−6.35%

Against its peers

Compare in full ›
NG2.F ALMR BIO ALERS.PA 4549.T MASS
Market cap 2.37B 1.90B 10.16B 265.30M 75.10B 457.56M
P/E (TTM) — — 48.2 37.6 40.7 —
Forward P/E 14.5 -65.9 39.0 23.3 24.9 -36.0
Price/book 1.3 6.2 1.4 1.4 1.7 3.3
Dividend yield — — — — 2.65% —
1-year change +100.19% +24.50% +23.96% +9.56% −6.77% +31.73%
Today +2.41% −9.36% +1.35% 0.00% +3.97% +3.75%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.

Latest news

All NG2.F news ›
BusinessLine·Positive

Broker’s Call: Neogen Chemicals (Buy)

Neogen Chemicals: Buy with ₹2,501 target as EV/BESS momentum and organolithium expansion support robust growth despite near-term costs. Target: ₹2,501 CMP: ₹2,186 Neogen Chemicals registered financials softer than our estimates amid…

InvestyWise·Positive

Neogen Chemicals reports 42% revenue growth in Q2 FY27

Neogen Chemicals Limited has announced its financial results for the second quarter and half-year ended September 30, 2026. The company reported a robust performance, with revenues growing 42% year-on-year to INR 296 crore. EBITDA also saw…

From the 4Search news index, newest first.

In the news

70mentions in 30 days
70with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 70 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance